Chemoinformaics analysis of Uridine
Molecular Weight | 244.203 | nRot | 2 |
Heavy Atom Molecular Weight | 232.107 | nRig | 13 |
Exact Molecular Weight | 244.07 | nRing | 2 |
Solubility: LogS | -0.933 | nHRing | 2 |
Solubility: LogP | -1.968 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
nHA | 7 | APOL | 30.0435 |
nHD | 4 | BPOL | 17.7905 |
QED | 0.444 |
Synth | 3.484 |
Natural Product Likeliness | 1.49 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.015 |
HIA | 0.944 |
CACO-2 | -6.001 |
MDCK | 0.00186046 |
BBB | 0.844 |
PPB | 0.12732 |
VDSS | 0.308 |
FU | 0.776439 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.102 |
CYP2c19-inh | 0.018 |
CYP2c19-sub | 0.048 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.092 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.101 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.02 |
CL | 5.065 |
T12 | 0.8 |
hERG | 0.005 |
Ames | 0.039 |
ROA | 0.022 |
SkinSen | 0.035 |
Carcinogencity | 0.028 |
EI | 0.009 |
Respiratory | 0.023 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.815258 |